SenzaGen has received another project to test chemicals with GARD®skin and GARD®potency worth around SEK 0.7 million. The project is a follow-on order from collaboration initiated in 2020 with one of the leading US-based chemicals companies with global operations, which demonstrates how much customers value the Company's tests. The tests will be performed at the company's GLP-certified laboratory in Lund.

The agreement includes an option for more tests in 2022. The company's GARD® test platform is designed for companies looking to increase the accuracy of their test results and ensure product safety while avoiding animal studies. The platform combines genomic data from human cells with machine learning, making the method both more effective and more accurate than traditional animal-based methods, including for formulations that are traditionally considered difficult to assess.